In addition, sh-IGF1R cSCCs showed a significant reduction in the expression of ITGAV and in the percentage of ITGAV+ cancer cells compared with sh-control ones (Fig. 5I-J and S5E-S5H), indicating a loss of plasticity following IGF1R abrogation. This evidence concerns the gene ITGAV and cancer.